Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Beth S Gottlieb

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Rheumatology (Oxford, England)|April 2, 2023
Paediatric rheumatologists do not score the physician's global assessment of juvenile idiopathic arthritis disease activity in the same wayMaria Backström, Maarit Tarkiainen, Beth S Gottlieb, et al.
Arthritis and Rheumatism|October 31, 2007
Gene expression profiling of peripheral blood from patients with untreated new-onset systemic juvenile idiopathic arthritis reveals molecular heterogeneity that may predict macrophage activation syndromeNdate Fall, Michael Barnes, Sherry Thornton, et al.
The Journal of Rheumatology|April 3, 2016
Identifying Targets for Improving Mental Healthcare of Adolescents with Systemic Lupus Erythematosus: Perspectives from Pediatric Rheumatology Clinicians in the United States and CanadaAndrea M Knight, Michelle E Vickery, Eyal Muscal, et al.
Seminars in Arthritis and Rheumatism|December 10, 2023
Defining patient perception of overall well-being and disease activity in the OMERACT Juvenile Idiopathic Arthritis (JIA) core domain set: A report from the JIA working groupErin Balay-Dustrude, Robin Christensen, Alessandro Consolaro, et al.
The Journal of Rheumatology|September 3, 2014
Extension study of participants from the trial of early aggressive therapy in juvenile idiopathic arthritisCarol A Wallace, Sarah Ringold, John Bohnsack, et al.
Arthritis Care & Research|September 16, 2010
Measuring process of arthritis care: a proposed set of quality measures for the process of care in juvenile idiopathic arthritisDaniel J Lovell, Murray H Passo, Timothy Beukelman, et al.
Arthritis and Rheumatism|July 1, 2009
Gene expression signatures in polyarticular juvenile idiopathic arthritis demonstrate disease heterogeneity and offer a molecular classification of disease subsetsThomas A Griffin, Michael G Barnes, Norman T Ilowite, et al.
The Journal of Rheumatology|February 9, 2018
Barriers to Adherence in Juvenile Idiopathic Arthritis: A Multicenter Collaborative Experience and Preliminary ResultsLeslie A Favier, Janalee Taylor, Kristin Loiselle Rich, et al.
Pediatric Rheumatology Online Journal|July 25, 2014
Safety of celecoxib and nonselective nonsteroidal anti-inflammatory drugs in juvenile idiopathic arthritis: results of the Phase 4 registryRachel E Sobel, Daniel J Lovell, Hermine I Brunner, et al.
Arthritis and Rheumatism|July 1, 2009
Subtype-specific peripheral blood gene expression profiles in recent-onset juvenile idiopathic arthritisMichael G Barnes, Alexei A Grom, Susan D Thompson, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Rheumatology (Oxford, England)|April 2, 2023
Paediatric rheumatologists do not score the physician's global assessment of juvenile idiopathic arthritis disease activity in the same wayMaria Backström, Maarit Tarkiainen, Beth S Gottlieb, et al.
Arthritis and Rheumatism|October 31, 2007
Gene expression profiling of peripheral blood from patients with untreated new-onset systemic juvenile idiopathic arthritis reveals molecular heterogeneity that may predict macrophage activation syndromeNdate Fall, Michael Barnes, Sherry Thornton, et al.
The Journal of Rheumatology|April 3, 2016
Identifying Targets for Improving Mental Healthcare of Adolescents with Systemic Lupus Erythematosus: Perspectives from Pediatric Rheumatology Clinicians in the United States and CanadaAndrea M Knight, Michelle E Vickery, Eyal Muscal, et al.
Seminars in Arthritis and Rheumatism|December 10, 2023
Defining patient perception of overall well-being and disease activity in the OMERACT Juvenile Idiopathic Arthritis (JIA) core domain set: A report from the JIA working groupErin Balay-Dustrude, Robin Christensen, Alessandro Consolaro, et al.
The Journal of Rheumatology|September 3, 2014
Extension study of participants from the trial of early aggressive therapy in juvenile idiopathic arthritisCarol A Wallace, Sarah Ringold, John Bohnsack, et al.
Arthritis Care & Research|September 16, 2010
Measuring process of arthritis care: a proposed set of quality measures for the process of care in juvenile idiopathic arthritisDaniel J Lovell, Murray H Passo, Timothy Beukelman, et al.
Arthritis and Rheumatism|July 1, 2009
Gene expression signatures in polyarticular juvenile idiopathic arthritis demonstrate disease heterogeneity and offer a molecular classification of disease subsetsThomas A Griffin, Michael G Barnes, Norman T Ilowite, et al.
The Journal of Rheumatology|February 9, 2018
Barriers to Adherence in Juvenile Idiopathic Arthritis: A Multicenter Collaborative Experience and Preliminary ResultsLeslie A Favier, Janalee Taylor, Kristin Loiselle Rich, et al.
Pediatric Rheumatology Online Journal|July 25, 2014
Safety of celecoxib and nonselective nonsteroidal anti-inflammatory drugs in juvenile idiopathic arthritis: results of the Phase 4 registryRachel E Sobel, Daniel J Lovell, Hermine I Brunner, et al.
Arthritis and Rheumatism|July 1, 2009
Subtype-specific peripheral blood gene expression profiles in recent-onset juvenile idiopathic arthritisMichael G Barnes, Alexei A Grom, Susan D Thompson, et al.
Pageof 4